Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 32 results for "mylan"

Biocon, Sandoz partner for immunology and cancer biosimilars' development
Business Standard

Biocon, Sandoz partner for immunology and cancer biosimilars' ...

Second large global tie-up for an Indian company after Mylan Raghu Krishnan | Bengaluru Last Updated at January 18, 2018 18:44 IST Kiran Mazumdar-Shaw Biocon has signed with Sandoz, the generics arm of the $48.52-billion Swiss Pharma giant Novartis to jointly ... Business Standard, 1 month ago

17 images for mylan

Money Today, 2 months ago
Business Standard, 1 month ago
Money Today, 2 months ago
Business Standard, 2 months ago
Money Control, 2 months ago
Money Control, 2 months ago
Business Standard, 2 months ago
Money Control, 2 months ago
Business Standard, 2 months ago
Money Control, 4 months ago
Business Standard

European regulator to review Biocon's anti-cancer drugs

The European Medicines Agency accepted for review the marketing authorization applications of Biocon and its US partner Mylan for their cancer treatment drugs Trastuzumab and Pegfilgrastim, said the leading biotech firm on Friday."EMA's acceptance to review ...
 Prokerala2 months ago Biocon updates on proposed biosimilars Trastuzumab and Pegfilgrastim  Business Standard2 months ago European drug regulator accepts Mylan's applications for 2 biosimilars  Business Standard2 months ago
Money Today

Mylan, Natco take early lead with enhanced safety profile generic drug for Hepatitis B

E Kumar Sharma New Delhi Last Updated: December 19, 2017 | 18:45 IST Two companies, one a global major, Mylan and the other, Hyderabad-headquartered niche pharma product-maker Natco Pharma, have taken an early lead in launching generic version of Tenofovir ...
 Money Today2 months ago Mylan Launches chronic hepatitis B treatment tablets in India  Business Standard2 months ago Mylan launches hepatitis B pill in India  Nerve2 months ago
Money Control

Biocon shares gain after Mylan gets EMA nod for biosimilars

The shares of Biocon opened at Rs 445, then surged 3.92 percent to touch an intra-day high of Rs 449.20 and finally settled for the day at Rs 446.55, up 3.31 percent over its previous closing price
 Money Control2 months ago Biocon surgest 15% on USFDA approval  Deccan Herald2 months ago Biocon surges 14% on USFDA nod for biosimilar of cancer drug  Business Standard2 months ago

FDA approves Mylan's copy of Allergan's vaginal cream

(Reuters) - Mylan NV said the U.S. Food and Drug Administration had granted it the approval for a generic version of Allergan's Estrace cream for vaginal atrophy.
 Reuters1 month ago

Indian Share Markets Open Flat; Yes Bank Top Gainer

Posted by Equitymaster Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.31% while the Hang Seng is up 0.07%. The Shanghai Composite is trading up by 0.35%. Meanwhile, Wall Street closed its Thursday ...
 Equitymaster.com1 month ago Sensex Opens Marginally Up; Sun Pharma & Tata Steel Top Gainers  Equitymaster.com1 month ago

Sensex Opens in Green; IT & Healthcare Stocks Gain

Posted by Equitymaster Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.16% while the Hang Seng is down 0.49%. The Nikkei 225 is trading down by 0.43%. Meanwhile, Wall Street paused its rally on ...
 Equitymaster.com1 month ago Sensex Opens Flat; Biocon Rallies 10%  Equitymaster.com2 months ago

Sensex Above 34K; Infosys, Bharti Airtel PSU Banks & Other Top Cues to Sway the Market Today

Posted by Equitymaster Indian share markets finished at fresh life-time highs on the last trading day of 2017, capping off a remarkable year which saw the benchmark surging by 28%. At the closing bell last week, the BSE Sensex closed higher by 209 points and ...
 Equitymaster.com1 month ago Sensex, Nifty Trade Marginally Lower; Biocon Rises 2%  Equitymaster.com2 months ago

Aurobindo gets USFDA nod for Fondaparinux Sodium injection

Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to prevent deep vein thrombosis.The approval by US Food & Drug Administration (USFDA) ...
 Business Standard1 month ago

Of Monetary Policy, IPO Analysis of Shalby Ltd and Top Stocks in Action Today

Posted by Equitymaster Monetary Policy to Keep the Markets Volatile in the Next Few Days After shedding off 770 points on concerns over fiscal deficit in the previous week, there was some marginal relief as the S&P BSE Sensex ended yesterday's trade in the ...
 Equitymaster.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less